Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126171881 | 12617188 | 1 | I | 20160725 | 20160803 | 20160803 | EXP | US-ZYDUS-011791 | ZYDUS PHARM | BOULL CL, HYLWA SA, SAJIC D, WAGNER JE, TOLAR J, HOOK KP. TOXIC EPIDERMAL NECROLYSIS IN RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA FOLLOWING BONE MARROW TRANSPLANTATION. J-PEDIATR 2016;173242-244. | 3.00 | YR | C | M | Y | 0.00000 | 20160803 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126171881 | 12617188 | 1 | PS | LEVOFLOXACIN. | LEVOFLOXACIN | 1 | Unknown | Y | UNKNOWN | 77652 | |||||||||
| 126171881 | 12617188 | 2 | SS | CEFAZOLIN | CEFAZOLIN | 1 | Unknown | Y | UNKNOWN | 0 | |||||||||
| 126171881 | 12617188 | 3 | SS | CEFTAZIDIME/CEFTAZIDIME PENTAHYDRATE | CEFTAZIDIME | 1 | Unknown | Y | UNKNOWN | 0 | |||||||||
| 126171881 | 12617188 | 4 | SS | CEFEPIME | CEFEPIME HYDROCHLORIDE | 1 | Unknown | Y | UNKNOWN | 0 | |||||||||
| 126171881 | 12617188 | 5 | SS | VANCOMYCIN | VANCOMYCIN | 1 | Unknown | Y | UNKNOWN | 0 | |||||||||
| 126171881 | 12617188 | 6 | SS | SULFAMETHOXAZOLE/TRIMETHOPRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Unknown | Y | UNKNOWN | 0 | |||||||||
| 126171881 | 12617188 | 7 | C | CICLOSPORIN | CYCLOSPORINE | 1 | Unknown | UNKNOWN | 0 | ||||||||||
| 126171881 | 12617188 | 8 | C | MYCOPHENOLIC ACID. | MYCOPHENOLIC ACID | 1 | Unknown | Y | UNKNOWN | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126171881 | 12617188 | 1 | Product used for unknown indication |
| 126171881 | 12617188 | 2 | Product used for unknown indication |
| 126171881 | 12617188 | 3 | Product used for unknown indication |
| 126171881 | 12617188 | 4 | Product used for unknown indication |
| 126171881 | 12617188 | 5 | Product used for unknown indication |
| 126171881 | 12617188 | 6 | Product used for unknown indication |
| 126171881 | 12617188 | 7 | Immunosuppressant drug therapy |
| 126171881 | 12617188 | 8 | Immunosuppressant drug therapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126171881 | 12617188 | HO |
| 126171881 | 12617188 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126171881 | 12617188 | Dehydration | |
| 126171881 | 12617188 | Dermatitis | |
| 126171881 | 12617188 | Dermatitis bullous | |
| 126171881 | 12617188 | Electrolyte imbalance | |
| 126171881 | 12617188 | Erythema | |
| 126171881 | 12617188 | Oral mucosal exfoliation | |
| 126171881 | 12617188 | Pancytopenia | |
| 126171881 | 12617188 | Papule | |
| 126171881 | 12617188 | Photophobia | |
| 126171881 | 12617188 | Pyrexia | |
| 126171881 | 12617188 | Rash papular | |
| 126171881 | 12617188 | Skin discolouration | |
| 126171881 | 12617188 | Skin exfoliation | |
| 126171881 | 12617188 | Skin hyperplasia | |
| 126171881 | 12617188 | Toxic epidermal necrolysis | |
| 126171881 | 12617188 | Urethral injury |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |